The American Tinnitus Association (ATA), headquartered in Vienna, VA has been a publicly supported 501(c)3 organization since 1971, with its Scientific Advisory Committee representing the top researchers in the field. The core purpose of the American Tinnitus Association is to promote relief, prevent, and eventually find cures for tinnitus, evidenced by its core values of compassion, credibility, and responsibility.

ATA promotes relief, prevents and focuses on finding cures for tinnitus by:


ATA helps patients and their allies better understand tinnitus, its causes, related conditions like hyperacusis, and the currently available management options that can minimize its impact. We do this by providing the best, most scientifically-grounded information on tinnitus. ATA also works to educate healthcare providers about tinnitus, in order to improve patient access to quality management services.


ATA is a vocal advocate for a patient community that needs to be heard. We work to increase public awareness of the condition and build support for improved patient support systems. ATA uses its national standing to address barriers in patient care and encourage increased federal funding for tinnitus research.


ATA is one of very few organizations that funds advanced, independent tinnitus and hyperacusis research. ATA supports cutting-edge science, with targeted, annual research grants to innovative and promising projects. Over the last 35 years, we have contributed over $6 million to the search for a cure.


Compassion and providing hope for people with tinnitus and hyperacusis is at the foundation of everything we do. ATA strives to be a trusted and helpful resource for these patients. Through our programs and interaction with the patient community, we are building a strong, mutually-supportive alliance across the country and around the world.

ATA will continue to provide these programmatic services until a definitive cure for tinnitus is found and all patients have access to the best medical treatment for their condition.